Jazz Pharmaceuticals PLC (JAZZ)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 5,107,990 | 5,693,340 | 6,018,940 | 1,848,520 | 1,573,870 |
| Total assets | US$ in thousands | 11,393,400 | 10,835,300 | 12,298,600 | 6,535,900 | 5,538,900 |
| Debt-to-assets ratio | 0.45 | 0.53 | 0.49 | 0.28 | 0.28 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $5,107,990K ÷ $11,393,400K
= 0.45
The debt-to-assets ratio of Jazz Pharmaceuticals plc has shown some fluctuations over the past five years. The ratio stood at 0.50 as of December 31, 2023, indicating that half of the company's assets were financed through debt. This ratio has decreased compared to the previous year when it was at 0.53 on December 31, 2022.
Looking further back, the ratio was higher at 0.49 on December 31, 2021, and significantly lower at 0.32 on December 31, 2020. The lowest ratio in the table was recorded on December 31, 2019, at 0.29, depicting a more conservative capital structure with a higher proportion of assets funded through equity.
Overall, the debt-to-assets ratio of Jazz Pharmaceuticals plc has fluctuated within a range over the years, suggesting varying levels of reliance on debt to finance its assets. Investors and stakeholders may monitor this ratio to assess the company's leverage and solvency levels.
Peer comparison
Dec 31, 2023